Christine H. Lee

Stephen T Rush, Christine H Lee, Washington Mio et al.

Scientific investigations that incorporate next generation sequencing involve analyses of high-dimensional data where the need to organize, collate and interpret the outcomes are pressingly important. Currently, data can be collected at the microbiome level leading to the possibility of personalized medicine whereby treatments can be tailored at this scale. In this paper, we lay down a statistical framework for this type of analysis with a view toward synthesis of products tailored to individual patients. Although the paper applies the technique to data for a particular infectious disease, the methodology is sufficiently rich to be expanded to other problems in medicine, especially those in which coincident `-omics' covariates and clinical responses are simultaneously captured.

Diego Hernán Díaz Martínez, Christine H. Lee, Peter T. Kim et al.

Many complex ecosystems, such as those formed by multiple microbial taxa, involve intricate interactions amongst various sub-communities. The most basic relationships are frequently modeled as co-occurrence networks in which the nodes represent the various players in the community and the weighted edges encode levels of interaction. In this setting, the composition of a community may be viewed as a probability distribution on the nodes of the network. This paper develops methods for modeling the organization of such data, as well as their Euclidean counterparts, across spatial scales. Using the notion of diffusion distance, we introduce diffusion Frechet functions and diffusion Frechet vectors associated with probability distributions on Euclidean space and the vertex set of a weighted network, respectively. We prove that these functional statistics are stable with respect to the Wasserstein distance between probability measures, thus yielding robust descriptors of their shapes. We apply the methodology to investigate bacterial communities in the human gut, seeking to characterize divergence from intestinal homeostasis in patients with Clostridium difficile infection (CDI) and the effects of fecal microbiota transplantation, a treatment used in CDI patients that has proven to be significantly more effective than traditional treatment with antibiotics. The proposed method proves useful in deriving a biomarker that might help elucidate the mechanisms that drive these processes.